• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

Dollar Tree shares jump after CEO Rick Dreiling steps down

by November 5, 2024
written by November 5, 2024

Investing.com — Shares in Dollar Tree (NASDAQ:DLTR) rose in premarket US trading after the budget store chain announced that Chief Executive Rick Dreiling had stepped down after almost two years in the role.

According to a company spokesperson quoted by Reuters, Dreiling’s decided to leave the position due to personal health challenges over the last two months.

Dreiling will be replaced by Chief Operating Officer Michael Creedon Jr. on an interim basis. Lead Independent Director Edward Kelly will also take over for Dreiling as Chairman of the company.

Dollar Tree said it was not searching among internal and external candidates for Dreiling’s successor.

Meanwhile, the firm backed its third-quarter outlook and reiterated its desire to undergo a strategic review of its operations, including the possible sale or spin-off of its Family Dollar unit.

“Mr. Dreiling was instrumental in a number of management changes and initiatives that have helped to invigorate the Dollar Tree and Family Dollar banners, in spite of a challenging consumer and competitive backdrop,” analysts at KeyBanc led by Bradley Thomas said in a note. “We believe this announcement will add incremental urgency to the Family Dollar strategic review process.”

Earlier this year, Dollar Tree unveiled plans to shut 970 Family Dollar locations, as it grapples with intensifying competition from bigger rivals like Walmart (NYSE:WMT) and Target in the race to attract inflation-hit consumers with lower prices. So far, 655 stores had been closed as of Aug. 3 and said it would shutter another 45 by the end of 2024.

Dollar Tree’s stock price has plummeted by more than 53% so far this year.

(Yasin Ebrahim and Reuters contributed reporting.)

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Earnings call: Fabrinet reports robust Q1 growth, eyes future expansion
next post
Earnings call: Sensata Technologies reports Q3 decline and strategic shifts

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!








    By signing up, you're cool with getting emails from us. Don’t worry — your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    Recent Posts

    • Elon Musk’s SpaceX acquires xAI

      February 25, 2026
    • The architect of Amazon’s supply chain on running a startup with your spouse

      February 25, 2026
    • Trump administration alleges Nike discriminated against white workers

      February 25, 2026
    • Landmark trial accusing social media companies of addicting children to their platforms begins

      February 25, 2026

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (688)
    • Stock (6,426)

    Latest News

    • Elon Musk’s SpaceX acquires xAI
    • The architect of Amazon’s supply chain on running a startup with your spouse

    Popular News

    • Belgium stocks higher at close of trade; BEL 20 up 0.07%
    • Eli Lilly Alzheimer’s drug donanemab approved in China

    About The Significant deals

    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy